Protein Substitute Requirements of Patients with Phenylketonuria on BH4 Treatment: A Systematic Review and Meta-Analysis
The traditional treatment for phenylketonuria (PKU) is a phenylalanine (Phe)-restricted diet, supplemented with a Phe-free/low-Phe protein substitute. Pharmaceutical treatment with synthetic tetrahydrobiopterin (BH4), an enzyme cofactor, allows a patient subgroup to relax their diet. However, dietar...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/13/3/1040 |
_version_ | 1797540293240684544 |
---|---|
author | Fatma Ilgaz Cyril Marsaux Alex Pinto Rani Singh Carmen Rohde Erdem Karabulut Hülya Gökmen-Özel Mirjam Kuhn Anita MacDonald |
author_facet | Fatma Ilgaz Cyril Marsaux Alex Pinto Rani Singh Carmen Rohde Erdem Karabulut Hülya Gökmen-Özel Mirjam Kuhn Anita MacDonald |
author_sort | Fatma Ilgaz |
collection | DOAJ |
description | The traditional treatment for phenylketonuria (PKU) is a phenylalanine (Phe)-restricted diet, supplemented with a Phe-free/low-Phe protein substitute. Pharmaceutical treatment with synthetic tetrahydrobiopterin (BH4), an enzyme cofactor, allows a patient subgroup to relax their diet. However, dietary protocols guiding the adjustments of protein equivalent intake from protein substitute with BH4 treatment are lacking. We systematically reviewed protein substitute usage with long-term BH4 therapy. Electronic databases were searched for articles published between January 2000 and March 2020. Eighteen studies (306 PKU patients) were eligible. Meta-analyses demonstrated a significant increase in Phe and natural protein intakes and a significant decrease in protein equivalent intake from protein substitute with cofactor therapy. Protein substitute could be discontinued in 51% of responsive patients, but was still required in 49%, despite improvement in Phe tolerance. Normal growth was maintained, but micronutrient deficiency was observed with BH4 treatment. A systematic protocol to increase natural protein intake while reducing protein substitute dose should be followed to ensure protein and micronutrient requirements are met and sustained. We propose recommendations to guide healthcare professionals when adjusting dietary prescriptions of PKU patients on BH4. Studies investigating new therapeutic options in PKU should systematically collect data on protein substitute and natural protein intakes, as well as other nutritional factors. |
first_indexed | 2024-03-10T12:58:03Z |
format | Article |
id | doaj.art-69b7b06de18e4a24a7bab4ffa9fe1a8e |
institution | Directory Open Access Journal |
issn | 2072-6643 |
language | English |
last_indexed | 2024-03-10T12:58:03Z |
publishDate | 2021-03-01 |
publisher | MDPI AG |
record_format | Article |
series | Nutrients |
spelling | doaj.art-69b7b06de18e4a24a7bab4ffa9fe1a8e2023-11-21T11:44:12ZengMDPI AGNutrients2072-66432021-03-01133104010.3390/nu13031040Protein Substitute Requirements of Patients with Phenylketonuria on BH4 Treatment: A Systematic Review and Meta-AnalysisFatma Ilgaz0Cyril Marsaux1Alex Pinto2Rani Singh3Carmen Rohde4Erdem Karabulut5Hülya Gökmen-Özel6Mirjam Kuhn7Anita MacDonald8Department of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University, 06100 Ankara, TurkeyDanone Nutricia Research, 3584CT Utrecht, The NetherlandsDepartment of Dietetics, Birmingham Women’s and Children’s Hospital, Birmingham B4 6NH, UKMetabolic Genetics Nutrition Program, Department of Human Genetics, Emory University, Atlanta, GA 30322, USADepartment of Paediatrics of the University Clinics Leipzig, University of Leipzig, 04103 Leipzig, GermanyDepartment of Biostatistics, Faculty of Medicine, Hacettepe University, 06100 Ankara, TurkeyDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University, 06100 Ankara, TurkeyDanone Nutricia Research, 3584CT Utrecht, The NetherlandsDepartment of Dietetics, Birmingham Women’s and Children’s Hospital, Birmingham B4 6NH, UKThe traditional treatment for phenylketonuria (PKU) is a phenylalanine (Phe)-restricted diet, supplemented with a Phe-free/low-Phe protein substitute. Pharmaceutical treatment with synthetic tetrahydrobiopterin (BH4), an enzyme cofactor, allows a patient subgroup to relax their diet. However, dietary protocols guiding the adjustments of protein equivalent intake from protein substitute with BH4 treatment are lacking. We systematically reviewed protein substitute usage with long-term BH4 therapy. Electronic databases were searched for articles published between January 2000 and March 2020. Eighteen studies (306 PKU patients) were eligible. Meta-analyses demonstrated a significant increase in Phe and natural protein intakes and a significant decrease in protein equivalent intake from protein substitute with cofactor therapy. Protein substitute could be discontinued in 51% of responsive patients, but was still required in 49%, despite improvement in Phe tolerance. Normal growth was maintained, but micronutrient deficiency was observed with BH4 treatment. A systematic protocol to increase natural protein intake while reducing protein substitute dose should be followed to ensure protein and micronutrient requirements are met and sustained. We propose recommendations to guide healthcare professionals when adjusting dietary prescriptions of PKU patients on BH4. Studies investigating new therapeutic options in PKU should systematically collect data on protein substitute and natural protein intakes, as well as other nutritional factors.https://www.mdpi.com/2072-6643/13/3/1040phenylalanine hydroxylase deficiencyhyperphenylalaninemiaPKUprotein substitutemedical formulaamino acid mixture |
spellingShingle | Fatma Ilgaz Cyril Marsaux Alex Pinto Rani Singh Carmen Rohde Erdem Karabulut Hülya Gökmen-Özel Mirjam Kuhn Anita MacDonald Protein Substitute Requirements of Patients with Phenylketonuria on BH4 Treatment: A Systematic Review and Meta-Analysis Nutrients phenylalanine hydroxylase deficiency hyperphenylalaninemia PKU protein substitute medical formula amino acid mixture |
title | Protein Substitute Requirements of Patients with Phenylketonuria on BH4 Treatment: A Systematic Review and Meta-Analysis |
title_full | Protein Substitute Requirements of Patients with Phenylketonuria on BH4 Treatment: A Systematic Review and Meta-Analysis |
title_fullStr | Protein Substitute Requirements of Patients with Phenylketonuria on BH4 Treatment: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Protein Substitute Requirements of Patients with Phenylketonuria on BH4 Treatment: A Systematic Review and Meta-Analysis |
title_short | Protein Substitute Requirements of Patients with Phenylketonuria on BH4 Treatment: A Systematic Review and Meta-Analysis |
title_sort | protein substitute requirements of patients with phenylketonuria on bh4 treatment a systematic review and meta analysis |
topic | phenylalanine hydroxylase deficiency hyperphenylalaninemia PKU protein substitute medical formula amino acid mixture |
url | https://www.mdpi.com/2072-6643/13/3/1040 |
work_keys_str_mv | AT fatmailgaz proteinsubstituterequirementsofpatientswithphenylketonuriaonbh4treatmentasystematicreviewandmetaanalysis AT cyrilmarsaux proteinsubstituterequirementsofpatientswithphenylketonuriaonbh4treatmentasystematicreviewandmetaanalysis AT alexpinto proteinsubstituterequirementsofpatientswithphenylketonuriaonbh4treatmentasystematicreviewandmetaanalysis AT ranisingh proteinsubstituterequirementsofpatientswithphenylketonuriaonbh4treatmentasystematicreviewandmetaanalysis AT carmenrohde proteinsubstituterequirementsofpatientswithphenylketonuriaonbh4treatmentasystematicreviewandmetaanalysis AT erdemkarabulut proteinsubstituterequirementsofpatientswithphenylketonuriaonbh4treatmentasystematicreviewandmetaanalysis AT hulyagokmenozel proteinsubstituterequirementsofpatientswithphenylketonuriaonbh4treatmentasystematicreviewandmetaanalysis AT mirjamkuhn proteinsubstituterequirementsofpatientswithphenylketonuriaonbh4treatmentasystematicreviewandmetaanalysis AT anitamacdonald proteinsubstituterequirementsofpatientswithphenylketonuriaonbh4treatmentasystematicreviewandmetaanalysis |